SSI Diagnostica Group Acquires Gulf Coast Scientific
April 28, 2025
SSI Diagnostica Group (Denmark) has acquired Gulf Coast Scientific, a Florida-based in‑vitro diagnostics company specializing in Urea Breath Testing for Helicobacter pylori. The deal expands SSI Diagnostica Group's gastrointestinal diagnostic portfolio and strengthens its footprint in the US clinical diagnostics market.
- Buyers
- SSI Diagnostica Group
- Targets
- Gulf Coast Scientific
- Industry
- Medical Devices
- Location
- Florida, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
United Digestive Acquires Gastroenterology Group of Naples and Gulfshore Endoscopy Center
February 15, 2023
Healthcare Services
United Digestive, a physician practice management organization based in Atlanta, announced the acquisition/partnership with Gastroenterology Group of Naples (GGN) and Gulfshore Endoscopy Center (GEC) in Naples, Florida. The deal expands United Digestive’s presence in southwest Florida and adds a GI physician practice and an affiliated endoscopy center to its platform.
-
SSI Diagnostica (Adelis portfolio) Acquires CTK Biotech
August 26, 2020
Medical Devices
Adelis Equity Partners portfolio company SSI Diagnostica has acquired US-based CTK Biotech to create a global rapid diagnostics leader focused on respiratory and tropical disease tests. The deal combines SSI Diagnostica's Nordic IVD capabilities and distribution with CTK's product development and manufacturing (headquartered in San Diego with a manufacturing plant in Beijing), and triggers a CEO change and several board appointments.
-
SSI Diagnostica (Adelis) Acquires TECHLAB, Inc. from Pharos Capital
August 22, 2022
Medical Devices
SSI Diagnostica, a portfolio company of Adelis Equity, has acquired TECHLAB, Inc. from Pharos Capital Group. The acquisition combines SSI Diagnostica's global distribution and production capabilities with TECHLAB's U.S. R&D and manufacturing to grow the combined diagnostics business; TECHLAB will continue operating from its Virginia facilities and retain its management team and workforce.
-
Clinigen Acquires SSI Strategy
November 21, 2025
Healthcare Services
Clinigen has completed the acquisition of SSI Strategy, adding SSI's strategic advisory capabilities and an established U.S. and European footprint to Clinigen's global pharmaceutical services platform. The deal brings over 200 employees (including ~145 consultants) and a deep biotech client base to Clinigen, expanding its end-to-end lifecycle services from clinical strategy through global commercialisation.
-
Remote Medical International Acquires SSI Group
July 1, 2020
Healthcare Services
Remote Medical International completed its acquisition of United Kingdom–based SSI Group on July 1. The deal expands Remote Medical's presence in the renewable energy sector and adds SSI's emergency response, global risk management and international safety capabilities to Remote Medical's workplace health and safety services; company leadership roles for SSI executives were retained and integrated into Remote Medical's global organization. Terms were not disclosed.
-
SSI Strategy Acquires NDA Group AB
August 15, 2023
Healthcare Services
SSI Strategy has entered into a definitive agreement to acquire NDA Group AB, a regulatory affairs and drug development consultancy, to create an integrated life sciences consultancy offering end-to-end drug development and regulatory services. The combination, supported by SSI's private equity partner Amulet Capital Partners, expands SSI's regulatory capabilities and geographic footprint across the U.S. and Europe.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.